Clinical manifestation of myeloperoxidase deficiency

Journal of Molecular Medicine

Volumn 76, Issue 10, 1998, Pages 676-681

  Lanza, Francesco ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Acute leukemia; EPO deficiency; Infections; Malignancies; MPO deficiency; MPO immunoreactivity

Indexed keywords

EOSINOPHIL PEROXIDASE; HEMOPROTEIN; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; CLINICAL FEATURE; DIABETES MELLITUS; ENZYME DEFICIENCY; HUMAN; IMMUNOREACTIVITY; INFECTION; LYSOSOME; MONOCYTE; NEUTROPHIL; REVIEW;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; EOSINOPHIL PEROXIDASE; EOSINOPHILS; HUMANS; LEUKEMIA; METABOLIC DISEASES; METABOLISM, INBORN ERRORS; NEOPLASMS; NEUTROPHILS; PEROXIDASE; PEROXIDASES;

EID: 0031713092     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050267     Document Type: Review

References (48)

1. Nauseef WM, Olsson I, Arnljots K (1988) Biosynthesis and processing of myeloperoxidase. A marker for myeloid cell differentiation. Eur J Haematol 40:97-110
2. Koeffler HP, Ranyard J, Pertcheck M (1985) Myeloperoxidase: its structure and expression during myeloid differentiation. Blood 65:484-491
3. Nauscef W (1986) Myeloperoxydase biosynthesis by a human promyelocytic leukemia cell line: insignth into myeloperoxidase deficiency. Blood 67:865-872
4. Stendahl O, Coble BI, Dahlgren C, Hed J, Molin L (1984) Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. J Clin Invest 73:366-373
5. Clark RA, Szot S (1981) The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophil mediated tumor cell cytoxicity. J Immunol 126:1295-1301
6. Sheinecker C, Strobl H, Fritsh G, Knapp W (1995) Granulomonocyte associated lysosomal protein expression during in vitro expansion and differentiation of CD34+ hematopoietic progenitor cells. Blood 86:4115-4121
7. Malech HL, Gallin JI (1987) Neutrophils in human diseases. N Engl J Med 317:687-694
8. Bogomolski V, Matzner Y (1995) Disorders of neutrophil function. Blood Rev 9:183-190
9. Cech P, Papathanassiou A, Boreux G, Roth P, Miescher PA (1979) Hereditary myeloperoxidase deficiency. Blood 53: 403-411
10. Kitahara M, Eyre HJ, Simonian Y, Atkin CL, Hasstedt SJ (1981) Hereditary myeloperoxidase deficiency. Blood 57:888-893
11. Parry M. F, Root R. K, Metcalf JA, Delaney KK, Kaplow LS, Richar WJ (1981) Myeloperoxidase deficiency. Ann Intern Med 95:293-301
12. Cramer R, Soranzo MR, Rottini GD, Bramezza M, Cirielli S, Patriarca P (1982) Incidence of myeloperoxidase deficiency in an area of northern Italy: histochemical, biochemical and functional studies. Br J Haematol 51:81-87
13. Larrocha C, De Castro MF, Fontan G, Viloria A, Chacon JLF, Jimenez C (1982) Hereditary myeloperoxidase deficiency: study of 12 cases. Scand J Haematol 29:389-397
14. Nauseef WM, Root RK, Malech HL (1983) Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest 71:1297-1307
15. Cappelletti P, Lippi U (1983) Hereditary myeloperoxidase deficiency: a rare condition? Diagnostic possibilities of a differential white cell autoanalyzer (Hemalog-D). Hematologica 68:736-741
16. Lippi U, Cappelletti P, Schinella M (1984) Catalytic activity of neutrophil and eosinophil peroxidase. Cytochemical and biochemical study in total hereditary myeloperoxidase deficiency. Nouv Rev Fr Hematol 26:35-38
17. Kaplow LS (1986) The relationship of myeloperoxidase activity to neutrophil maturity and other hematologic indicators of infection. Blood Cells Mol Dis 12:153-165
18. Cech P, Schneider P, Bachmann F (1982) Partial myeloperoxidase deficiency. Acta Haematol 67:180-184
19. Lanza F, Fietta A, Spisani S, Castoldi GL, Traniello S (1987) Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurence of neoplasms? J Clin Lab Immunol 22:175-180
20. Bos AJ, Weening RS, Hamers MN, Wever R, Behrendt H, Roos D (1982) Characterization of hereditary partial myeloperoxidase deficiency. J Lab Clin Med 99:589-600
21. Moretti S, Lanza F, Spisani S, Latorraca A, Rigolin GM, Giuliani AL, Castoldi GL, Traniello S (1994) Neutrophils from patients with myelodysplastic syndromes: relationship between impairment of granular contents, complement receptors, functional activities and disease status. Leuk Lymphoma 13:471-477
22. Rider ER, Christensen RD, Hall DC, Rothstein G (1988) Myeloperoxidase deficiency in neutrophils of neonates. J Pediatr 112:648-651
23. D'Onofrio G, Mancini R, Vallone R, Alfano G, Candido A, Palla M, Mango G (1983) Acquired neutrophil myeloperoxidase deficiency: an indicator of subclinical activation of blood coagulation? Blood Cells Mol Dis 9:455-464
24. Murakawa H, Bland C, Willis W, Dallman PR (1987) Iron deficiency and neutrophil function: different rates of correction of the depressions in oxidative burst and myeloperoxidase activity after iron treatment. Blood 69:1464-1468
25. Bozdech MJ, Bainton D, Mustacchi P (1980) Partial peroxidase deficiency in neutrophils and eosinophils associated with neurologic disease. Am J Clin Pathol 73:409-416
26. Lanza F, Castoldi GL, Masotti M (1988) Eosinophil peroxidase deficiency detected by the Technicon HI system. Ann Hematol 56:143-145
27. Kutter D, Mueller-Hagedorn S, Forges T, Glaesener R (1995) A case of eosinophil peroxidase deficiency. Ann Hematol 71: 315-317
28. Lanza F, Giuliani AL, Amelotti F, Spisani S, Traniello S, Castoldi GL (1988) Depressed neutrophil mediated tumor cell cytotoxicity in subjects affected by hereditary myeloperoxidase deficiency and secondary neoplasia. Hematologica 73:355-358
29. Weiss S, Lo Buglio AF (1980) An oxygen dependent mechanism of neutrophil mediated cytotoxicity. Blood 55:1020-1024
30. Abrams SI, Brahmi Z (1984) Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes. J Immunol 132:3192-3196
31. Clark R, Szot S (1981) The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity. J Immunol 126:1295-1301
32. Josephy PD (1996) The role of peroxidase-catalysed activation of aromatic amines in breast cancer. Mutagenesis 11:3-7
33. London SJ, Lehman TA, Taylor JA (1997) Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 57:5001-5003
34. Giri U, Sharma SD, Abdulla M, Athar M (1995) Evidence that in situ generated reactive oxygen species act as a potent stage I tumor promoter in mouse skin. Biochem Biophys Res Commun 209:698-705
35. Lanza F, Latorraca A, Musto P, Ferrari L, Moretti S, Zabucchi G, Carotenuto M, Castoldi GL (1991) Cytochemically unreactive neutrophils from subjects with myeloperoxidase (MPO) deficiency show a complex pattern of immunoreactivity with anti-MPO monoclonal antibodies: a flow cytometric and immunocytochemical study. Ann Hematol 63:94-100
36. Knapp W, Strobl H, Majdic O (1994) Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 18:187-198
37. Lanza F, Moretti S, Latorraca A, Ferrari L, Castagnari B, Castoldi GL (1996) Cytofluorimetric measurement of cytoplasmic myeloperoxidase by permeabilisation of blood cells with the Facs lysing solution. Cytometry 24:292-295
38. Van Der Shoot CE, Daams GM, Pinkster J, Vet R, Von Dem Borne A (1990) Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia. Br J Haematol 74:173-178
39. Lanza F, Latorraca A, Moretti S, Castagnari B, Ferrari L, Castoldi GL (1997) Comparative analysis of different permeabilisation methods for the flow cytometric measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Cytometry 30:134-144
40. Benè M, Castoldi GL, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB (on behalf of the European Group for the Immunological Characterization of Leukemias) (1995) Proposals for the immunological classification of acute leukemias. Leukemia 9:1783-1786
41. Bernier M, Massy M, Deleeuw N, Bron D, Debusscher L, Strickmans P (1995) Immunological definition of acute minimally differentiated myeloid leukemia (MO) and acute undifferentiated leukemia (AUL). Leuk Lymphoma 18:13-17
42. Campana D, Thompson JS, Amlot P, Brown S, Janossy G (1987) The cytoplasmic expression of CD3 antigens in normal and malignant cells of T-lymphoid lineage. Ann Intern Med 103: 620-626
43. Ma W, Hu ZB, Drexler HG (1994) Sensitivity of different methods for the detection of myeloperoxidase in leukemia cells. Leukemia 8:336-342
44. Groeneveld K, Marvelde JG, van den Beemd MW, Hooijkaas H, van Dongen JJM (1996) Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia 10:1383-1389
45. Lanza F, Campana D, Knapp W, Janossy G, Lacombe F, Matutes E, Orfao A, Schmitz G (1996) Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Eur J Histochem 40:7-14
46. Papa S, Lanza F (1996) Immunophenotyping haematological malignancies. Ponzio, Pavia
47. Brando B, Sommaruga E (1993) Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy. Cytometry 14:294-306
48. Poncelet P, George F, Papa S, Lanza F (1996) Quantitation of hemopoietic cell antigens in flow cytometry. Eur J Histochem 40 [Suppl 1]:15-32